DrugPatentWatch Database Preview
Drugs in Development Information for Gliolan
Email this page to a colleague
What is the development status for investigational drug Gliolan?
Gliolan is an investigational drug.
There have been 16 clinical trials for Gliolan.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Glioblastoma, Brain Neoplasms, and Glioma. The leading clinical trial sponsors are Constantinos Hadjipanayis, National Cancer Institute (NCI), and University Hospital, Lille.
Summary for Gliolan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 190 |
| WIPO Patent Applications | 94 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 3 (2010-11-01) |
| Vendors | 97 |
Recent Clinical Trials for Gliolan
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors | medac GmbH | Phase 2 |
| Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors | photonamic GmbH & Co. KG | Phase 2 |
| Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors | Westfälische Wilhelms-Universität Münster | Phase 2 |
Clinical Trial Summary for Gliolan
Top disease conditions for Gliolan
Top clinical trial sponsors for Gliolan
US Patents for Gliolan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
